In order to show the effect of ESR1 and ESR2 promoter methylation and demethylation on gene expression, prostate cancer cell lines LNCaP, DU145 and PC3 were treated with 5-aza-2′-deoxycytidine (AZA). This evidence concerns the gene ESR2 and prostate carcinoma.